[1]
“Maternal Docosahexaenoic Acid Supplementation and Infant Neurodevelopmental Outcomes at Twelve Months: A Randomized, Placebo-Controlled Trial”, JCNFS, vol. 8, no. 1, pp. 9–16, Aug. 2025, doi: 10.5281/zenodo.22343522.